[Federal Register Volume 66, Number 199 (Monday, October 15, 2001)]
[Notices]
[Page 52444]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-25820]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Advisory Committee on Research on Women's Health.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Advisory Committee on Research on Women's 
Health.
    Date: November 1-2, 2001.
    Time: 9 a.m. to 1 p.m.
    Agenda: To provide advice on appropriate research activities 
with respect to women's health and related studies to be undertaken 
by the national research institutes, to provide recommendations 
regarding ORWH activities, and to assist in monitoring compliance 
regarding the inclusion of women in clinical research.
    Place: 9000 Rockville Pike, Building 31, Conference Room 10, 
Bethesda, MD 20892.
    Contact Person: Joyce Rudick, Director, Programs & Management, 
Office of Research on Women's Health, Office of the Director, 
National Institutes of Health, Building 1, Room 201, Bethesda, MD 
20892, 301/402-1770.
    Information is also available on the Institute's/Center's home 
page: www4.od.nih.gov/orwh/, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Programs Nos. 93.14, 
Intramural Research Training Award; 93.187, Undergraduate 
Scholarship Program for Individuals from Disadvantaged Backgrounds; 
93.22, Clinical Research Loan Repayment Program for Individuals from 
Disadvantaged Backgrounds; 93.232, Loan Repayment Program for 
Research Generally; 93.39, Academic Research Enhancement Award; 
93.936, NIH Acquired Immunodeficiency Syndrome Research Loan 
Repayment Program, National Institutes of Health, HHS)

    Dated: October 4, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-25820 Filed 10-12-01; 8:45 am]
BILLING CODE 4140-01-M